HiringMany openings

Natera careers

Cell-free DNA testing company building molecular diagnostics across oncology, women's health, and organ health, including Signatera, Panorama, and Prospera.

Live
·
37 roles tracked
·
0 tracking
Track Natera from Claude, Cursor, Codex, Windsurf

Open roles at Natera

35 roles
Director of Bioinformatics and Machine Learning
San Carlos, CA / On-site / $228,600 - $285,800/year
Oracle Fusion SCM Functional Lead
San Carlos, CA / On-site / $154,600 - $193,300/year
Finance Functional Lead, Oracle Fusion Cloud
United States / Remote (Restricted) / $161,500 - $195,400/year
Contract Design Control Scientist
South San Francisco / Hybrid
Bioinformatics Scientist
San Carlos, CA / On-site / $106,600 - $133,300/year
Staff Biostatistician (Clinical Validation)
United States / Remote (Restricted) / $164,000 - $205,000/year
Senior Product Manager, Sales, Marketing & Business Solutions
United States / Remote (Restricted) / $140,600 - $175,700/year
(Associate) Product Manager, Organ Health
Austin, TX / Remote (Restricted) / $70,200 - $100,800/year
Principal Software Engineer
South San Francisco / Hybrid / $219,800 - $274,700/year
Manager of Statistical Programming
United States / Remote (Restricted) / $132,000 - $165,350/year
NextPage 1 of 4
2 more roles we track at Natera aren't published here yet, so you'll find them on the company's careers page.
ApexGoJava Star to unlock
Star Natera to see their full tech stack.

About

Natera describes itself as a global leader in cell free DNA testing, developing molecular diagnostic tests that help inform more personalized health care decisions. The work spans three areas: oncology, women's health, and organ health.

In oncology the portfolio includes Signatera for molecular residual disease testing, Altera for tumor genomic profiling, and Empower for hereditary cancer screening. Women's health covers Panorama for noninvasive prenatal testing, Horizon for carrier screening, Vistara for single gene NIPT, and Anora for miscarriage testing. Organ health covers the Prospera portfolio for kidney, heart, lung, and liver transplant assessment, alongside Renasight, a kidney gene panel.

Testing runs in CAP and CLIA certified laboratories, and the company says its tests have been validated across more than 400 peer reviewed publications. Hiring spans laboratory, clinical, and commercial roles alongside software engineering.